BPC-157 + TB-500 Blend (10mg (5mg + 5mg)) Dosage Protocol
A synergistic healing blend combining BPC-157 (5mg) and TB-500 (5mg). This combination leverages complementary mechanisms for comprehensive tissue repair support - BPC-157 for gut and tendon healing, TB-500 for systemic tissue regeneration.
Add 2.0 mL bacteriostatic water → 5 mg/mL total (2.5 mg/mL each)
300-500 mcg daily (150-250 mcg of each peptide)
At 5 mg/mL: 6 units = 300 mcg, 10 units = 500 mcg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-2 (Loading) | 500 mcg daily | 10 units |
| Weeks 3-4 | 400 mcg daily | 8 units |
| Weeks 5-8 (Maintenance) | 300 mcg daily | 6 units |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date, concentration, and contents
This blend combines two complementary healing peptides. BPC-157 modulates nitric oxide pathways, promotes angiogenesis, and has cytoprotective effects particularly in the GI tract and tendons. TB-500 (Thymosin Beta-4 fragment) promotes cell migration, reduces inflammation, and supports tissue regeneration through actin regulation. Together they provide multi-pathway healing support.
- Synergistic tissue repair mechanisms
- Supports tendon, ligament, and muscle healing
- Anti-inflammatory effects from both peptides
- May accelerate recovery from injuries
- Gut healing support from BPC-157 component
- Sikiric P, et al. BPC 157 and wound healing. Front Pharmacol. 2021
- Goldstein AL, et al. Thymosin beta-4: a multi-functional peptide. Expert Opin Biol Ther. 2012
- Gwyer D, et al. BPC-157 and TB-500 in healing. J Orthop Surg Res. 2019
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Can inject near injury site or subcutaneously in abdomen
- •Research compounds - not FDA approved
- •Can be injected locally near injury or systemically
- •Loading phase followed by maintenance recommended
- •Rotate injection sites to prevent irritation
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.